Repeated Target Vessel Revascularization After Coronary Artery Bypass for In-Stent Restenosis Jung-Hwan Kim, MD, Seung Hyun Lee, MD, PhD, Hyun-Chel Joo, MD, Kyung-Jong Yoo, MD, PhD, Young-Nam Youn, MD, PhD The Annals of Thoracic Surgery Volume 104, Issue 4, Pages 1332-1339 (October 2017) DOI: 10.1016/j.athoracsur.2017.03.034 Copyright © 2017 The Society of Thoracic Surgeons Terms and Conditions
Fig 1 (A) Overall survival curve and rates of freedom from (B) major adverse cardiac and cerebrovascular events (MACCE) and (C) target vessel revascularization (TVR) curve in the no-stent group (blue line) compared with the stent group (green line) in the propensity-matched population using the Kaplan-Meier method. The Annals of Thoracic Surgery 2017 104, 1332-1339DOI: (10.1016/j.athoracsur.2017.03.034) Copyright © 2017 The Society of Thoracic Surgeons Terms and Conditions
Fig 2 Rates of freedom from (A) major adverse cardiac and cerebrovascular events (MACCEs) and (B) target vessel revascularization (TVR) in the in-stent restenosis (ISR) group (green line) compared with the no-ISR group (blue line) and the no-stent group (red line) using the Kaplan-Meier method. The Annals of Thoracic Surgery 2017 104, 1332-1339DOI: (10.1016/j.athoracsur.2017.03.034) Copyright © 2017 The Society of Thoracic Surgeons Terms and Conditions